Why have pediatric brain tumor cure rates lagged behind the cure rates for other pediatric malignant cancers? Dr. James Olson, associate professor of pediatrics at the University of Washington School of Medicine, joins host Dr. Mark Nolan Hill to explain the discrepancy, and talk about exciting advances in brain tumor research.
Pediatric Brain Tumor Research
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Why have pediatric brain tumor cure rates lagged behind the cure rates for other pediatric malignant cancers? Dr. James Olson, associate professor of pediatrics at the University of Washington School of Medicine, joins host Dr. Mark Nolan Hill to explain the discrepancy, and talk about exciting advances in brain tumor research.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
HF Management for Patients with Comorbid Conditions
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?